Another hallmark of endothelial dysfunction is a deficiency in the bioavailability of NO, and diabetes-induced inhibition of nitric oxide is attributable to the inhibition of eNOS, but it is not clear whether it is related to TRPV1. Here, TRPV1 is linked to endothelial dysfunction.